The Shuttle Has Hurt Space Science

The upcoming flight of the space shuttle Discovery brings a glimmer of light in the dark tunnel of space science in the United States. For the first time in over two years, there is hope that some of the experiments and space probes gathering dust in laboratories will finally get off the ground. But any rejoicing will probably be muted. The fact is that the shuttle has hurt the space science program. It contributed very little while it was flying, and the Challenger accident disrupted the space

Written byBurt Edelson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

But any rejoicing will probably be muted. The fact is that the shuttle has hurt the space science program. It contributed very little while it was flying, and the Challenger accident disrupted the space science program very badly. Payloads almost never flew when scheduled. In fact, no major scientific payloads were ever launched by the shuttle.

This isn't to say that we should never have built the shuttle. Unlike James Van Allen, I believe that manned space flight is essential for several reasons—to maintain public support, to perform certain servicing and repair functions in space, for exploration, and for science. The shuttle and the space station do have the potential to establish new and important fields, such as space biology and medicine, and materials processing in a microgravity environment.

Unfortunately, we are still a long way from realizing this potential. In the development of the shuttle and during its first ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies